Sanofi, GSK expect to seek vaccine authorization in late 2021

“We believe that this vaccine candidate can make a significant contribution to the ongoing fight against COVID-19 and will move to Phase 3 as soon as possible to meet our goal of making it available before the end of the year,” Roger Connor, president of GSK Vaccines, said in a statement. The companies also said they would test the possibility of booster shots.

View original article here Source

Related Posts